Consumers’ interest in foods that are nutritionally balanced and with health benefits has increased. The food industry is paying attention to the use of the ancestral seed Salvia hispanica L., commonly known as chia. At present, only chia seeds, which are a natural source of omega-3 and omega-6, fiber, proteins, and natural antioxidants, are commercialized. Although some studies reveal the presence of several bioactive compounds, such as polyphenols (e.g., vitexin, orientin, and some hydroxycinnamic acids) in chia leaf methanolic extracts, the chia plant is commonly used as fertilizer or treated as waste after harvest. Therefore, it can represent a by-product that could be considered a great source of bioactive compounds with unexplored potential in medicine and food industry applications. In this work, UHPLC-HRMS (Q-Orbitrap) was employed to tentatively identify and determine the bioactive compounds present in different leaf extracts of chia plants of black and white seed phenotype obtained with solvents of different polarity (ethanol, ethyl acetate, dichloromethane, and hexane) to address chia plant by-product revalorization. The chemical antioxidant capacity was also studied and correlated to the found bioactive compounds. In these experiments, black chia showed a higher antioxidant capacity than white chia in the ethanolic extracts. Moreover, experiments on cellular antioxidant activity were also performed with a predominance of the white chia extract. It is noted that the cellular antioxidant activity results make chia ethanolic extracts promising antioxidants.

The bacterium Helicobacter pylori (H. pylori) represents a major risk factor associated with the development of gastric cancer. The anti-oxidant curcumin has been ascribed many benefits to human health, including bactericidal effects. However, these effects are poorly reproducible because the molecule is extremely unstable and water insoluble. Here we solubilized curcumin as either nanoemulsions or chitosan nanocapsules and tested the effects on H. pylori. The nanoemulsions were on average 200 nm in diameter with a PdI ≤ 0.16 and a negative zeta potential (−54 mV), while the nanocapsules were 305 nm in diameter with a PdI ≤ 0.29 and a positive zeta potential (+68 mV). Nanocapsules were safer than nanoemulsions when testing effects on the viability of GES-1 gastric cells. Also, nanocapsules were more efficient than nanoemulsions at inhibiting H. pylori growth (minimal inhibitory concentration: 50 and 75 μM, respectively), whereby chitosan contributed to this activity. Importantly, both formulations effectively diminished H. pylori’s adherence to and internalization by GES-1 cells, as well as biofilm formation. In summary, the demonstrated activity of the curcumin nanoformulations described here against H. pylori posit them as having great potential to treat or complement other therapies currently in use against H. pylori infection.

Obesity is a significant health concern affecting 13% of the world’s population. It is often associated with insulin resistance and metabolic-associated fatty liver disease (MAFLD), which can cause chronic inflammation in the liver and adipose tissue. Obese hepatocytes show increased lipid droplets and lipid peroxidation, which can lead to the progression of liver damage. Polyphenols have been shown to have the ability to reduce lipid peroxidation, thereby promoting hepatocyte health. Chia leaves, a by-product of chia seed production, are a natural source of bioactive antioxidant compounds, such as cinnamic acids and flavonoids, which have antioxidant and anti-inflammatory properties. In this study, chia leaves’ ethanolic extracts of two seed phenotypes were tested on diet-induced obese mice to evaluate their therapeutic potential. Results show that the chia leaf extract positively affected insulin resistance and lipid peroxidation in the liver. In addition, the extract improved the HOMA-IR index compared to the obese control group, reducing the number and size of lipid droplets and lipid peroxidation. These results suggest that chia leaf extract may help treat insulin resistance and liver damage associated with MAFLD.

Quitral (Tristerix corymbosus), a Chilean and Argentine parasitic mistletoe, is traditionally used by Mapuche natives to treat stomach ulcers, nervous disorders, and cholesterol reduction, although scientific support is scarce. Methanolic and chloroform extracts from its leaves and stems were prepared. Chemical analysis included antioxidant capacity assays (ORAC-FL and DPPH) and chromatographic determinations. The antimicrobial activity was tested against nine bacteria and two yeast strains. Additionally, cytotoxicity (hemolysis) and toxicity (against Caenorhabditis elegans) assays were performed. The results revealed that the methanolic leaf extracts had the highest ORAC-FL value, with DPPH assays showing solvent-dependent differences. Thirty-one compounds were tentatively identified, of which 61% were phenolic compounds, primarily flavonoids like quercetin and its derivatives. Antimicrobial results showed activity against Gram-positive bacteria (Staphylococcus aureus, Listeria monocytogenes, Bacillus cereus, and Enterococcus faecalis), but not against yeast Candida guillermondii and Candida tropicalis. Methanolic extracts induced dose-dependent erythrocyte hemolysis, while chloroform extracts showed no relevant cytotoxicity. Toxicity against Caenorhabditis elegans was also dose-dependent for methanolic extracts; leaf extract reduced survival at 50 mg mL⁻¹ after 24 h. These findings partially validate some traditional uses, highlight the importance of solvent polarity in extraction and biological effects, and establish quitral as a flavonoid source.

Background/Objectives: The increasing emergence of antimicrobial-resistant Staphylococcus pseudintermedius has limited the effectiveness of conventional therapies for canine pyoderma, highlighting the need for alternative topical strategies. This study aimed to develop hydrogels incorporating essential oils (EOs) from Peumo (Cryptocarya alba) and Tepa (Laureliopsis philippiana) as potential topical treatments against Staphylococcus pseudintermedius skin infections in veterinary medicine. Methods: EOs were obtained by steam distillation, chemically characterized by gas chromatography–mass spectrometry (GC–MS), and evaluated for antibacterial activity against S. pseudintermedius strains. Carbopol^®-based hydrogels incorporating the EOs of C. alba (HCA), L. philippiana (HLP), and a control vehicle (HVE) were formulated and characterized in terms of physicochemical properties, microbiological safety, and stability under accelerated and refrigerated conditions. Preclinical dermal safety was evaluated in BALB/c mice by repeated topical administration for five days. The analysis included clinical observation, skin irritation scoring, and histological analysis. Additionally, a preliminary microbiological evaluation was conducted in client-owned dogs with superficial pyoderma to assess the performance of the formulations in the target species. Skin lesion swabs were collected at baseline and after 21 days of treatment, followed by bacterial culture and automated identification using the VITEK^® system. Bacterial detection and bacterial load were evaluated to determine changes in microbiological status over the treatment period. Results: GC–MS analysis identified sabinene and eucalyptol as the main compounds in CA-EO, and linalool, eucalyptol, and safrole in L. philippiana EO. Both EOs exhibited moderate antibacterial activity against S. pseudintermedius (inhibition zones 4.9–10.8 mm; MIC ≥ 2.048 mg mL⁻¹). The hydrogels were microbiologically safe. Among formulations, HLP demonstrated superior physical stability and comparable rheological properties to the vehicle. In vivo safety evaluation demonstrated no signs of systemic toxicity, behavioral alterations, or skin irritation, and histological analysis confirmed preserved skin architecture without evidence of inflammation or tissue damage. In the preliminary microbiological evaluation in dogs, all animals were positive for Staphylococcus spp. at baseline. On Day 21, bacterial elimination was observed in the active treatment groups, but not in the HVE group, with elimination rates of 50.0% for Inveclor^® and 25.0% for both HCA and HLP. In parallel, HLP showed the highest proportion of dogs reaching minimal bacterial load levels (75%), followed by Inveclor^® (50.0%) and HCA (37.5%), whereas no dogs in the vehicle group reached this category. Conclusions: EOs from C. alba and L. philippiana presented antibacterial activity and were successfully incorporated into microbiologically safe hydrogel formulations. Notably, HLP demonstrated superior stability and a favorable preclinical safety profile, supporting its potential. In the preliminary microbiological evaluation in dogs, numerical differences in bacterial elimination and bacterial load categories were observed among groups; however, these differences were not statistically significant and should be interpreted as exploratory.